Signaling Pathways Regulating Dimorphism in Medically Relevant Fungal Species
Pathogens · 04.04.2025 · 14 (4) · 350
DOI: 10.3390/pathogens14040350 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 04.04.2025. Verfasst von Uriel Ramírez-Sotelo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, Gu…. Hauptthemen laut MEDLINE: Signal Transduction, Fungi, Mycoses. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación.
Abstract (Originalsprache)
Pathogenic fungi that exhibit the ability to alternate between hyphal and yeast morphology in response to environmental stimuli are considered dimorphic. Under saprobic conditions, some fungi exist as filamentous hyphae, producing conidia. When conidia are inhaled by mammals or traumatically inoculated, body temperature (37 °C) triggers dimorphism into yeast cells. This shift promotes fungal dissemination and immune evasion. Some fungal pathogens undergo dimorphism in the contrary way, forming pseudohyphae and hyphae within the host. While temperature is a major driver of dimorphism, other factors, including CO2 concentration, pH, nitrogen sources, and quorum-sensing molecules, also contribute to morphological shifts. This morphological transition is associated with increased expression of virulence factors that aid in adhesion, colonization, and immune evasion. Candida albicans is a fungus that is commonly found as a commensal on human mucous membranes but has the potential to be an opportunistic fungal pathogen of immunocompromised patients. C. albicans exhibits a dimorphic change from the yeast form to the hyphal form when it becomes established as a pathogen. In contrast, Histoplasma capsulatum is an environmental dimorphic fungus where human infection begins when conidia or hyphal fragments of the fungus are inhaled into the alveoli, where the dimorphic change to yeast occurs, this being the morphology associated with its pathogenic phase. This review examines the main signaling pathways that have been mostly related to fungal dimorphism, using as a basis the information available in the literature on H. capsulatum and C. albicans because these fungi have been widely studied for the morphological transition from hypha to yeast and from yeast to hypha, respectively. In addition, we have included the reported findings of these signaling pathways associated with the dimorphism of other pathogenic fungi, such as Paracoccidioides brasiliensis, Sporothrix schenckii, Cryptococcus neoformans, and Blastomyces dermatitis. Understanding these pathways is essential for advancing therapeutic approaches against systemic fungal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, Guanajuato C.P. 36050, Mexico.
ORCID-Profile: Uriel Ramírez-Sotelo, Héctor M Mora-Montes
Förderung
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
Zitieren
APA
Ramírez-Sotelo, U., Gómez-Gaviria, M., & Mora-Montes, H. M. (2025). Signaling Pathways Regulating Dimorphism in Medically Relevant Fungal Species. Pathogens, 14(4), 350. https://doi.org/10.3390/pathogens14040350
Vancouver
Ramírez-Sotelo U, Gómez-Gaviria M, Mora-Montes HM. Signaling Pathways Regulating Dimorphism in Medically Relevant Fungal Species. Pathogens. 2025;14(4):350. doi:10.3390/pathogens14040350
BibTeX
@article{RamrezSotelo2025,
author = {Ramírez-Sotelo, Uriel and Gómez-Gaviria, Manuela and Mora-Montes, Héctor M},
title = {Signaling Pathways Regulating Dimorphism in Medically Relevant Fungal Species},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {4},
pages = {350},
doi = {10.3390/pathogens14040350}
}
EUVIMED